We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+7.8%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$484B
AUM Growth
+$29.1B
Cap. Flow
-$16.6B
Cap. Flow %
-3.43%
Top 10 Hldgs %
36.47%
Holding
15,826
New
1,205
Increased
5,575
Reduced
7,223
Closed
1,562

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$545M
2
DXCM icon
DexCom
DXCM
+$457M
3
T icon
AT&T
T
+$431M
4
PANW icon
Palo Alto Networks
PANW
+$416M
5
HUM icon
Humana
HUM
+$394M

Sector Composition

Rank Sector Weight
1 Technology 3.03%
2 Healthcare 2.92%
3 Consumer Discretionary 1.99%
4 Financials 1.93%
5 Industrials 1.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DSL
8326
DoubleLine Income Solutions Fund
DSL
$1.22B
$402K ﹤0.01%
33,763
+10,058
+42% +$117K
TILE icon
8327
CALL
Interface
TILE
$2.27B
$402K ﹤0.01%
45,700
+2,300
+5% +$17.6K
EVGO icon
8328
PUT
EVgo
EVGO
$481M
$402K ﹤0.01%
100,400
+27,100
+37% +$138K
JAKK icon
8329
CALL
Jakks Pacific
JAKK
$291M
$401K ﹤0.01%
20,100
+14,800
+279% +$321K
IQSM icon
8330
IQ Candriam US Mid Cap Equity ETF
IQSM
$343M
$401K ﹤0.01%
+14,142
New +$380K
FXH icon
8331
CALL
First Trust Health Care AlphaDEX Fund
FXH
$1.15B
$401K ﹤0.01%
3,700
+3,100
+517% +$332K
ZNTL icon
8332
CALL
Zentalis Pharmaceuticals
ZNTL
$274M
$401K ﹤0.01%
14,200
-100
-0.7% -$2.4K
INTF icon
8333
iShares International Equity Factor ETF
INTF
$3.75B
$401K ﹤0.01%
+14,940
New +$400K
SHOO icon
8334
PUT
Steven Madden
SHOO
$3.46B
$399K ﹤0.01%
12,200
+2,000
+20% +$66.7K
IUS icon
8335
Invesco RAFI Strategic US ETF
IUS
$968M
$399K ﹤0.01%
9,838
-15,216
-61% -$591K
EE icon
8336
CALL
Excelerate Energy
EE
$1.2B
$398K ﹤0.01%
19,600
-21,800
-53% -$455K
CRMD icon
8337
PUT
CorMedix
CRMD
$664M
$398K ﹤0.01%
100,400
-8,800
-8% -$43.5K
MPX
8338
CALL
DELISTED
Marine Products Corp
MPX
$398K ﹤0.01%
23,600
-1,400
-6% -$20.7K
BKH icon
8339
PUT
Black Hills Corp
BKH
$5.58B
$398K ﹤0.01%
6,600
-4,200
-39% -$266K
DAKT icon
8340
CALL
Daktronics
DAKT
$942M
$397K ﹤0.01%
62,100
+3,500
+6% +$20.5K
VPL icon
8341
CALL
Vanguard FTSE Pacific ETF
VPL
$8.44B
$397K ﹤0.01%
5,700
-8,200
-59% -$566K
HNI icon
8342
CALL
HNI Corp
HNI
$3.49B
$397K ﹤0.01%
14,100
+7,100
+101% +$189K
NSPL
8343
DELISTED
NightShares 500 1x/1.5x ETF
NSPL
$397K ﹤0.01%
+11,371
New +$375K
GASS icon
8344
StealthGas
GASS
$360M
$397K ﹤0.01%
93,239
-28,328
-23% -$85.8K
BCAB icon
8345
BioAtla
BCAB
$5.45M
$397K ﹤0.01%
2,648
-7,605
-74% -$1.31M
CSTE icon
8346
Caesarstone
CSTE
$117M
$397K ﹤0.01%
75,759
-15,003
-17% -$68K
FOLD
8347
CALL
DELISTED
Amicus Therapeutics
FOLD
$397K ﹤0.01%
31,600
-4,100
-11% -$48.7K
EU
8348
enCore Energy
EU
$210M
$397K ﹤0.01%
164,641
+137,785
+513% +$308K
RARE icon
8349
PUT
Ultragenyx Pharmaceutical
RARE
$2.59B
$397K ﹤0.01%
8,600
-800
-9% -$37.1K
AMPH icon
8350
CALL
Amphastar Pharmaceuticals
AMPH
$925M
$397K ﹤0.01%
6,900
+1,200
+21% +$53.2K

Similar funds

Ken Griffin's Q2 2023 Portfolio in Review

As of Q2 2023, Ken Griffin held 15,826 positions worth $484B, up 6.4% from $455B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Ken Griffin withdrew a net $16.6B in Q2 2023, closing 1,562 positions and reducing 7,223 holdings. Its most notable exit was State Street Industrial Select Sector SPDR ETF, an estimated $192M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.2% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Ken Griffin opened a new position in BILL Holdings worth $222M.

  • Ken Griffin's largest Q2 2023 buy was BILL Holdings: 1,901,064 shares worth $222M.
  • Ken Griffin added most to Microsoft in Q2 2023, an estimated $640M increase.
  • Ken Griffin's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $545M.
  • Ken Griffin fully exited State Street Industrial Select Sector SPDR ETF in Q2 2023, selling an estimated $192M.
  • Ken Griffin's ten largest holdings make up 36% of its $484B portfolio in Q2 2023.
  • Ken Griffin opened 1,205 new positions and closed 1,562 in Q2 2023.
  • Ken Griffin's portfolio value rose 6.4% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.